The value of audiovisual sexual stimulation with virtual reality in diagnosing erectile dysfunction.

IF 2.6 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Sexual Medicine Pub Date : 2024-03-17 eCollection Date: 2024-02-01 DOI:10.1093/sexmed/qfae014
Yan-Ping Huang, Tao Jing, Kai-Feng Liu, Wei Liu, Ming Zhang, Da-Chuan Zhong, Yi-Dong Liu, Shi-Ran Xu, Mu-Jun Lu
{"title":"The value of audiovisual sexual stimulation with virtual reality in diagnosing erectile dysfunction.","authors":"Yan-Ping Huang, Tao Jing, Kai-Feng Liu, Wei Liu, Ming Zhang, Da-Chuan Zhong, Yi-Dong Liu, Shi-Ran Xu, Mu-Jun Lu","doi":"10.1093/sexmed/qfae014","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The traditional audiovisual sexual stimulation (AVSS) test may experience limitations including low erectile response rate and lack of unified diagnostic criteria.</p><p><strong>Aim: </strong>We aimed to explore the clinical value of AVSS with virtual reality (VR-AVSS) test in assessing erectile function and diagnosing erectile dysfunction (ED).</p><p><strong>Methods: </strong>Participants 18 to 60 years of age were screened for analysis in 3 clinical centers from June 2020 to March 2022. Demographic data, 5-item International Index of Erectile Function (IIEF-5), erectile hardness score (EHS), and self-reported symptom questions were collected. The ED patients and control patients were confirmed according to the IIEF-5 and EHS. All subjects watched a 60-minute erotic video by VR device during RigiScan recording. The parameters including tip average rigidity, tip effective erectile duration (duration of rigidity ≥60%, tip effective erectile duration), base average rigidity, and base effective erectile duration were evaluated.</p><p><strong>Outcomes: </strong>The main outcome of interest was the application of VR immersion technology to improve the traditional AVSS test.</p><p><strong>Results: </strong>A total of 301 ED cases and 100 eligible control patients were included for final analysis. Compared with control patients, ED cases had significantly lower IIEF-5 scores, EHS, positive response rate, and erectile rigidity and duration. The positive response rate of ED and control patients were 75.5% and 90.9%, respectively. The cutoff points of tip average rigidity, tip effective erectile duration, base average rigidity, and base effective erectile duration were 40.5% (sensitivity: 77.6%, specificity: 70.2%; <i>P</i> < .001), 4.75 minutes (sensitivity: 75.9%, specificity: 75.4%; <i>P</i> < .001), 48.5% (sensitivity: 77.6%, specificity: 75.1%; <i>P</i> < .001), and 7.75 minutes (sensitivity: 79.3%, specificity: 75.7%; <i>P</i> < .001).</p><p><strong>Clinical implications: </strong>The technological superiority of VR will enable the VR-AVSS immersion test to be a more accurate detection than traditional AVSS modes.</p><p><strong>Strengths and limitations: </strong>Our study applied VR immersion technology to establish the standard operation procedure for the AVSS test, which could effectively reduce the interference of adverse factors and minimize the detecting errors. However, the test data only included positive response subjects, so the true erectile status of men with a negative response to the AVSS test cannot be obtained.</p><p><strong>Conclusions: </strong>The VR-AVSS test can effectively improve the diagnostic accuracy of ED. The average rigidity and effective erectile duration were the optimal diagnostic parameters for excluding ED.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"12 1","pages":"qfae014"},"PeriodicalIF":2.6000,"publicationDate":"2024-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10944820/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sexmed/qfae014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The traditional audiovisual sexual stimulation (AVSS) test may experience limitations including low erectile response rate and lack of unified diagnostic criteria.

Aim: We aimed to explore the clinical value of AVSS with virtual reality (VR-AVSS) test in assessing erectile function and diagnosing erectile dysfunction (ED).

Methods: Participants 18 to 60 years of age were screened for analysis in 3 clinical centers from June 2020 to March 2022. Demographic data, 5-item International Index of Erectile Function (IIEF-5), erectile hardness score (EHS), and self-reported symptom questions were collected. The ED patients and control patients were confirmed according to the IIEF-5 and EHS. All subjects watched a 60-minute erotic video by VR device during RigiScan recording. The parameters including tip average rigidity, tip effective erectile duration (duration of rigidity ≥60%, tip effective erectile duration), base average rigidity, and base effective erectile duration were evaluated.

Outcomes: The main outcome of interest was the application of VR immersion technology to improve the traditional AVSS test.

Results: A total of 301 ED cases and 100 eligible control patients were included for final analysis. Compared with control patients, ED cases had significantly lower IIEF-5 scores, EHS, positive response rate, and erectile rigidity and duration. The positive response rate of ED and control patients were 75.5% and 90.9%, respectively. The cutoff points of tip average rigidity, tip effective erectile duration, base average rigidity, and base effective erectile duration were 40.5% (sensitivity: 77.6%, specificity: 70.2%; P < .001), 4.75 minutes (sensitivity: 75.9%, specificity: 75.4%; P < .001), 48.5% (sensitivity: 77.6%, specificity: 75.1%; P < .001), and 7.75 minutes (sensitivity: 79.3%, specificity: 75.7%; P < .001).

Clinical implications: The technological superiority of VR will enable the VR-AVSS immersion test to be a more accurate detection than traditional AVSS modes.

Strengths and limitations: Our study applied VR immersion technology to establish the standard operation procedure for the AVSS test, which could effectively reduce the interference of adverse factors and minimize the detecting errors. However, the test data only included positive response subjects, so the true erectile status of men with a negative response to the AVSS test cannot be obtained.

Conclusions: The VR-AVSS test can effectively improve the diagnostic accuracy of ED. The average rigidity and effective erectile duration were the optimal diagnostic parameters for excluding ED.

虚拟现实视听性刺激在诊断勃起功能障碍中的价值。
背景:目的:我们旨在探讨虚拟现实性刺激(VR-AVSS)测试在评估勃起功能和诊断勃起功能障碍(ED)方面的临床价值:2020年6月至2022年3月,在3个临床中心对18至60岁的参与者进行筛选分析。收集人口统计学数据、5 项国际勃起功能指数(IIEF-5)、勃起硬度评分(EHS)和自述症状问题。根据 IIEF-5 和 EHS 确认 ED 患者和对照组患者。在 RigiScan 扫描过程中,所有受试者都通过 VR 设备观看了 60 分钟的情色视频。评估参数包括顶端平均勃起硬度、顶端有效勃起持续时间(勃起硬度≥60%的持续时间,即顶端有效勃起持续时间)、基底平均勃起硬度和基底有效勃起持续时间:主要结果是应用 VR 沉浸技术改进传统的 AVSS 测试:最终分析共纳入了 301 例 ED 患者和 100 例符合条件的对照组患者。与对照组患者相比,ED 病例的 IIEF-5 评分、EHS、阳性反应率、勃起硬度和持续时间均明显较低。ED患者和对照组患者的阳性反应率分别为75.5%和90.9%。尖端平均硬度、尖端有效勃起持续时间、基础平均硬度和基础有效勃起持续时间的临界点分别为 40.5%(灵敏度:77.6%,特异性:70.2%;P < .001)、4.75 分钟(灵敏度:75.9%,特异性:75.4%;P < .001)、48.5%(灵敏度:77.6%,特异性:75.1%;P < .001)和 7.75 分钟(灵敏度:79.3%,特异性:75.7%;P < .001):VR的技术优势将使VR-AVSS浸入式测试比传统AVSS模式的检测更准确:我们的研究应用 VR 沉浸技术建立了 AVSS 检测的标准操作流程,可有效减少不利因素的干扰,将检测误差降至最低。然而,测试数据仅包括阳性反应受试者,因此无法获得AVSS测试阴性反应男性的真实勃起状态:结论:VR-AVSS 测试能有效提高 ED 诊断的准确性。平均硬度和有效勃起时间是排除 ED 的最佳诊断参数。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sexual Medicine
Sexual Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.40
自引率
0.00%
发文量
103
审稿时长
22 weeks
期刊介绍: Sexual Medicine is an official publication of the International Society for Sexual Medicine, and serves the field as the peer-reviewed, open access journal for rapid dissemination of multidisciplinary clinical and basic research in all areas of global sexual medicine, and particularly acts as a venue for topics of regional or sub-specialty interest. The journal is focused on issues in clinical medicine and epidemiology but also publishes basic science papers with particular relevance to specific populations. Sexual Medicine offers clinicians and researchers a rapid route to publication and the opportunity to publish in a broadly distributed and highly visible global forum. The journal publishes high quality articles from all over the world and actively seeks submissions from countries with expanding sexual medicine communities. Sexual Medicine relies on the same expert panel of editors and reviewers as The Journal of Sexual Medicine and Sexual Medicine Reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信